The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure

Krens, SD; Lubberman, FJE; van Egmond, M; Jansman, FGA; Burger, DM; Hamberg, P; Vervenne, WL; Gelderblom, H; van der Graaf, WTA; Desar, IME; van Herpen, CML; van Erp, NP

Krens, SD (corresponding author), Radboud Inst Hlth Sci, Dept Pharm, POB 9101, NL-6500 HB Nijmegen, Netherlands.

INTERNATIONAL JOURNAL OF CANCER, 2021; 148 (11): 2799

Abstract

Co-treatment with gastric acid suppressants (GAS) in patients taking anticancer drugs that exhibit pH-dependant absorption may lead to decreased drug ......

Full Text Link